93 733 Pill - pink round, 8mm
Pill with imprint 93 733 is Pink, Round and has been identified as Metoprolol Tartrate 50 mg. It is supplied by Teva Pharmaceuticals USA.
Metoprolol is used in the treatment of Heart Failure; Angina; High Blood Pressure; Angina Pectoris Prophylaxis; Heart Attack and belongs to the drug class cardioselective beta blockers. Risk cannot be ruled out during pregnancy. Metoprolol 50 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 93 733
Metoprolol Tartrate
- Imprint
- 93 733
- Strength
- 50 mg
- Color
- Pink
- Size
- 8.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Cardioselective beta blockers
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA
- Inactive Ingredients
-
silicon dioxide,
hypromellose 2910 (3 mPa.s),
lactose monohydrate,
magnesium stearate,
polyethylene glycol 400,
povidone k30,
propylene glycol,
sodium starch glycolate type A potato,
magnesium silicate,
titanium dioxide,
D&C Red No. 30,
aluminum oxide
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00093-0733 (Discontinued) | Teva Pharmaceuticals USA, Inc. |
| 54569-3787 | A-S Medication Solutions, LLC (repackager) |
Related images for "93 733"
More about metoprolol
- Check interactions
- Compare alternatives
- Reviews (649)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: cardioselective beta blockers
- Breastfeeding
- En español
Patient resources
- Metoprolol drug information
- Metoprolol (Intravenous) (Advanced Reading)
- Metoprolol Extended-Release Tablets
Other brands
Professional resources
- Metoprolol monograph
- Metoprolol (FDA)
- Metoprolol Succinate (FDA)
- Metoprolol Succinate ER Capsules (FDA)
- Metoprolol Succinate ER Tablets (FDA)
Other brands
Toprol-XL, Lopressor, Kapspargo Sprinkle
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.